TNF-alpha employs a protein-tyrosine phosphatase to inhibit activation of hepatocyte growth factor receptor and hepatocyte growth factor-induced endothelial cell proliferation

Molecular and Cellular Biochemistry

Volumn 322, Issue 1-2, 2009, Pages 113-117

  Sugano, Masahiro ^a   Iwasaki, Yoshiko ^a   Abe, Masako ^a   Maeda, Toyoki ^b   Tsuchida, Keiko ^b   Makino, Naoki ^b  

^a OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Endothelial cells; Hepatocyte growth factor receptor; Protein tyrosine phosphatase; TNF alpha

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VANADATE SODIUM;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-MET; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59349091831     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9946-7     Document Type: Article

References (27)

1. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Therapeutic angiogenesis: A single intraarterial bonus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662-670
2. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW, Simons M (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1:1085-1089
3. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF (1994) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189
4. Harada K, Friedman M, Lopez JJ, Wang SY, Li J, Prasad PV, Pearlman JD, Edelman ER, Sellke FW, Simons M (1996) Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270:H1791-H1802
5. Stolpen AH, Guinan EC, Fiers W, Pober JS (1986) Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 123(1):16-24
6. Sato N, Goto T, Haranaka K, Satomi N, Nariuchi H, Mano-Hirano Y, Sawasaki Y (1986) Actions of tumor necrosis factor on cultured vascular endothelial cells: Morphologic modulation, growth inhibition, and cytotoxicity. J Nat Cancer Inst 76(6):1113-1121
7. Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee MN, Haber E (1996) Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 98:490-496
8. Guo DQ, Wu LW, Dunbar JD, Ozes ON, Mayo LD, Kessler KM, Gustin JA, Baerwald MR, Jaffe EA, Warren RS, Donner DB (2000) Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 275:11216-11221
9. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S (1997) Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95:2552-2558
10. Bussolino F, DiRenzo MF, Ziche M, Bocchietto E, Olivero M, Naidini L, Gaudino G, Tmagnone L, Coffer A, Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629-641
11. Hayashi S, Morishita R, Higaki J, Aoki M, Motiguchi A, Kida I, Yoshiki S, Matsumoto K, Nakamura T, Kanada Y, Ogihara T (1996) Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun 220:539-545
12. Morishita R, Nakamura S, Hayashi S, Taniyama Y, Motiguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1999) Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33:1379-1384
13. Yo Y, Morishita R, Nakamura S, Tomita N, Yamamoto K, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1998) Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int 54:1392-1393
14. Duan HF, Wu CT, Lu Y, Wang H, Liu HJ, Zhang QW, Jia XX, Lu ZZ, Wang LS (2004) Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. Exp Cell Res 298:593-601
15. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P (1987) Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Nat Acad Sci 84:5277-5281
16. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630-632
17. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW (1997) Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: Estradiol as a survival factor. Circulation 95:1505-1514
18. Sata M, Walsh K (1998) TNF α regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nature Med 4:415-420
19. Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T (2001) Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: Preclinical study for treatment of peripheral arterial disease. Gene Ther 8:181-189
20. Lei X, Buja LM (1996) Detection and localization of tumor necrosis factor-alpha in WHHL rabbit arteries. Atherosclerosis 125:81-89
21. Tanaka H, Swanson SI, Sukhova G, Schoen FI, Libby P (1995) Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-α and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 147:617-626
22. Clausell N, de Lima VC, Molossi S, Liu P, Turley E, Gotlieb AI, Adelman AG, Rabinovitch M (1995) Expression of tumor necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesion retrieved by atherectomy. Br Heart J 73:534-539
23. Tanaka H, Sukhova G, Schwartz D, Libby P (1996) Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 16:12-18
24. Sugano M, Tsuchida K, Makino N (2004) Intramuscular gene transfer of soluble TNF-alpha receptor 1 activates vascular endothelial growth factor receptor (KDR/flk-1) and accelerates angiogenesis in a rat model of hindlimb ischemia. Circulation 109:797-802
25. Sugano M, Tsuchida K, Makino N (2004) A protein tyrosine phosphatase inhibitor accelerates angiogenesis in a rat model of hindlimb ischemia. J Cardiovasc Pharmacol 44:460-465
26. Sugano M, Tsuchida K, Maeda T, Makino N (2007) SiRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia. Atherosclerosis 191:33-39
27. Nakagami H, Cui TX, Iwai M, Shiuchi T, Takeda-Matsubara Y, Wu L, Horiuchi M (2002) Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells. Arterioscler Thromb Vasc Biol 22:238-242